{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:25:49Z","timestamp":1782451549458,"version":"3.54.5"},"reference-count":77,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Breast cancer is a heterogeneous disease that exists in multiple subtypes, some of which still lack targeted and effective therapy. A major challenge is to unravel their underlying molecular mechanisms and bring to light novel therapeutic targets. In this study, we investigated the role of WNT-inducible signaling pathway protein 1 (WISP1) matricellular protein in the acquirement of an invasive phenotype by breast cancer cells. To this aim, we treated non-invasive MCF7 cells with WISP1 and assessed the expression levels of macrophage migration inhibitory factor (MIF) and its cellular receptor CD74. Next, we examined the expression of epithelial-to-mesenchymal transition (EMT) markers as well as molecular effectors of the tumor microenvironment, such as CD44, the main hyaluronan receptor that also acts as a co-receptor for MIF, the hyaluronan oncogenic network, and specific matrix metalloproteinases (MMPs) and their endogenous inhibitors, tissue inhibitors of metalloproteinases (TIMPs). The results showed that WISP1 potently induces the expression of MIF cytokine and affects the expression of specific extracellular matrix molecules with established roles in the promotion of malignant properties. Notably, Src kinases and MIF are critically involved in these processes. Collectively, the present study demonstrates for first time a WISP1\/Src\/MIF axis as well as its ability to induce an invasive phenotype in MCF7 cells and highlights novel cellular and molecular processes involved in the epithelial-to-mesenchymal transition and the development of invasive breast cancer. This suggests that specific cues from the tumor microenvironment can activate a migratory\/invasive phenotype in a subpopulation of cells residing within the heterogeneous breast tumor.<\/jats:p>","DOI":"10.3390\/cells15020160","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:31:41Z","timestamp":1768480301000},"page":"160","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The WISP1\/Src\/MIF Axis Promotes the Malignant Phenotype of Non-Invasive MCF7 Breast Cancer Cells"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2282-5022","authenticated-orcid":false,"given":"Maria-Elpida","family":"Christopoulou","sequence":"first","affiliation":[{"name":"Biochemistry, Biochemical Analysis & Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece"},{"name":"Department of Pneumology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Karamitsou","sequence":"additional","affiliation":[{"name":"Biochemistry, Biochemical Analysis & Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexios","family":"Aletras","sequence":"additional","affiliation":[{"name":"Biochemistry, Biochemical Analysis & Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-2896","authenticated-orcid":false,"given":"Spyros S.","family":"Skandalis","sequence":"additional","affiliation":[{"name":"Biochemistry, Biochemical Analysis & Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Fumagalli, C., and Barberis, M. (2021). Breast Cancer Heterogeneity. Diagnostics, 11.","DOI":"10.3390\/diagnostics11091555"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41416-021-01328-7","article-title":"Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression","volume":"125","author":"Luond","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.trecan.2017.09.001","article-title":"Breast Cancer: Multiple Subtypes within a Tumor?","volume":"3","author":"Yeo","year":"2017","journal-title":"Trends Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccell.2016.02.002","article-title":"A Preclinical Model for ER\u03b1-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response","volume":"29","author":"Sflomos","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Li, J.J., Tsang, J.Y., and Tse, G.M. (2021). Tumor Microenvironment in Breast Cancer-Updates on Therapeutic Implications and Pathologic Assessment. Cancers, 13.","DOI":"10.3390\/cancers13164233"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Fico, F., and Santamaria-Martinez, A. (2020). The Tumor Microenvironment as a Driving Force of Breast Cancer Stem Cell Plasticity. Cancers, 12.","DOI":"10.3390\/cancers12123863"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Skandalis, S.S. (2023). CD44 Intracellular Domain: A Long Tale of a Short Tail. Cancers, 15.","DOI":"10.3390\/cancers15205041"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13046-022-02476-1","article-title":"Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications","volume":"41","author":"Asleh","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wang, Y., and Minden, A. (2022). Current Molecular Combination Therapies Used for the Treatment of Breast Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911046"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Christopoulou, M.E., Aletras, A.J., Papakonstantinou, E., Stolz, D., and Skandalis, S.S. (2024). WISP1 and Macrophage Migration Inhibitory Factor in Respiratory Inflammation: Novel Insights and Therapeutic Potentials for Asthma and COPD. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251810049"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1038\/s41467-020-19657-1","article-title":"Wisp1 is a circulating factor that stimulates proliferation of adult mouse and human beta cells","volume":"11","author":"Esteban","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1038\/s41467-020-16827-z","article-title":"Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma","volume":"11","author":"Tao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"14004","DOI":"10.1074\/jbc.M114.628818","article-title":"WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt Signaling","volume":"290","author":"Maeda","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"49834","DOI":"10.18632\/oncotarget.10486","article-title":"High expression of WISP1 in colon cancer is associated with apoptosis, invasion and poor prognosis","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_17","first-page":"3997","article-title":"PTEN Insufficiency Increases Breast Cancer Cell Metastasis In Vitro and In Vivo in a Xenograft Zebrafish Model","volume":"36","author":"Chiang","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12967-019-1769-7","article-title":"The emerging role of WISP proteins in tumorigenesis and cancer therapy","volume":"17","author":"Liu","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_19","first-page":"8917","article-title":"Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features","volume":"61","author":"Xie","year":"2001","journal-title":"Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1074\/jbc.RA118.006122","article-title":"WNT1-inducible signaling pathway protein 1 (WISP1\/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition","volume":"294","author":"Deng","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3390\/cancers11121903","article-title":"WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells Via the miR-153-3p\/Snail Axis","volume":"11","author":"Chang","year":"2019","journal-title":"Cancers"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/CAD.0000000000001687","article-title":"WISP1 inhibition of YAP phosphorylation drives breast cancer growth and chemoresistance via TEAD4 activation","volume":"36","author":"Dong","year":"2025","journal-title":"Anticancer Drugs"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3892\/ijo.2015.3185","article-title":"Macrophage migration inhibitory factor involvement in breast cancer (Review)","volume":"47","author":"Richard","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/or.2014.3272","article-title":"Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer","volume":"32","author":"Richard","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41419-020-02992-y","article-title":"Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer","volume":"11","author":"Charan","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Verjans, E., Noetzel, E., Bektas, N., Schutz, A.K., Lue, H., Lennartz, B., Hartmann, A., Dahl, E., and Bernhagen, J. (2009). Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-230"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Mora Barthelmess, R., Stijlemans, B., and Van Ginderachter, J.A. (2023). Hallmarks of Cancer Affected by the MIF Cytokine Family. Cancers, 15.","DOI":"10.3390\/cancers15020395"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2007.11.028","article-title":"Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer","volume":"261","author":"Xu","year":"2008","journal-title":"Cancer Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/qjmed\/hcq148","article-title":"Inflammation and cancer: Macrophage migration inhibitory factor (MIF)\u2014The potential missing link","volume":"103","author":"Conroy","year":"2010","journal-title":"QJM"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cellsig.2003.07.002","article-title":"Mechanisms and effectors of MIF-dependent promotion of tumourigenesis","volume":"16","author":"Mitchell","year":"2004","journal-title":"Cell. Signal."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10650","DOI":"10.18632\/oncotarget.12890","article-title":"Macrophage migration inhibitory factor: A potential driver and biomarker for head and neck squamous cell carcinoma","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Valdez, C.N., S\u00e1nchez-Zuno, G.A., Bucala, R., and Tran, T.T. (2024). Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25094849"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"C850","DOI":"10.1152\/ajpcell.00410.2023","article-title":"WISP1 induces the expression of macrophage migration inhibitory factor in human lung fibroblasts through Src kinases and EGFR-activated signaling pathways","volume":"326","author":"Christopoulou","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e1581545","DOI":"10.1080\/2162402X.2019.1581545","article-title":"WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors","volume":"8","author":"Gaudreau","year":"2019","journal-title":"Oncoimmunology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1038\/srep08686","article-title":"WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer","volume":"5","author":"Chiang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/2211-5463.70074","article-title":"Matrix: A complex amalgam of structures and functions in tumor microenvironment","volume":"15","author":"Skandalis","year":"2025","journal-title":"FEBS Open Bio"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Niland, S., Riscanevo, A.X., and Eble, J.A. (2021). Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010146"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Christopoulou, M.E., Papakonstantinou, E., and Stolz, D. (2023). Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043786"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2147\/CMAR.S133915","article-title":"The role of CCN4\/WISP-1 in the cancerous phenotype","volume":"10","author":"Nivison","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3892\/ol.2017.6313","article-title":"WNT1-inducible signaling pathway protein-1 contributes to tumor progression and treatment failure in oral squamous cell carcinoma","volume":"14","author":"Jung","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_41","first-page":"10445","article-title":"High expression of WISP1 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma","volume":"24","author":"Wang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e54127","DOI":"10.15252\/embr.202154127","article-title":"Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma","volume":"23","author":"Fernandez","year":"2022","journal-title":"EMBO Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1245\/s10434-007-9376-x","article-title":"Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer","volume":"14","author":"Davies","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.canlet.2016.02.005","article-title":"Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1\/TLR4\/NF kappa B axis","volume":"375","author":"Lv","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Balogh, K.N., Templeton, D.J., and Cross, J.V. (2018). Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197702"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.4049\/jimmunol.1201161","article-title":"Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment","volume":"189","author":"Simpson","year":"2012","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e21575","DOI":"10.1097\/MD.0000000000021575","article-title":"Prognostic significance of macrophage migration inhibitory factor expression in cancer patients: A systematic review and meta-analysis","volume":"99","author":"Koh","year":"2020","journal-title":"Medicine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.lfs.2016.05.036","article-title":"Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis","volume":"157","author":"Patel","year":"2016","journal-title":"Life Sci."},{"key":"ref_49","first-page":"987","article-title":"The influence of hormones on CD44 expression in endometrial and breast carcinomas","volume":"8","author":"Durst","year":"2001","journal-title":"Oncol. Rep."},{"key":"ref_50","first-page":"5424","article-title":"CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer","volume":"55","author":"Friedrichs","year":"1995","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"68303","DOI":"10.18632\/oncotarget.11945","article-title":"CD74 interacts with CD44 and enhances tumorigenesis and metastasis via RHOA-mediated cofilin phosphorylation in human breast cancer cells","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.12688\/f1000research.15782.1","article-title":"Cell-cell adhesion: Linking Wnt\/beta-catenin signaling with partial EMT and stemness traits in tumorigenesis","volume":"7","author":"Basu","year":"2018","journal-title":"F1000Research"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Santarosa, M., and Maestro, R. (2021). The Autophagic Route of E-Cadherin and Cell Adhesion Molecules in Cancer Progression. Cancers, 13.","DOI":"10.3390\/cancers13246328"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","article-title":"CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex","volume":"25","author":"Shi","year":"2006","journal-title":"Immunity"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellsig.2019.01.006","article-title":"Evolving complexity of MIF signaling","volume":"57","author":"Jankauskas","year":"2019","journal-title":"Cell. Signal."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1530\/EC-19-0442","article-title":"Leptin induces cell migration and invasion in a FAK-Src-dependent manner in breast cancer cells","volume":"8","year":"2019","journal-title":"Endocr. Connect."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e101302","DOI":"10.15252\/embj.2018101302","article-title":"The tumor cell-secreted matricellular protein WISP1 drives pro-metastatic collagen linearization","volume":"38","author":"Jia","year":"2019","journal-title":"EMBO J."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Vitale, D.L., Parnigoni, A., Viola, M., Karousou, E., Sevic, I., Moretto, P., Passi, A., Alaniz, L., and Vigetti, D. (2024). Deciphering Drug Resistance: Investigating the Emerging Role of Hyaluronan Metabolism and Signaling and Tumor Extracellular Matrix in Cancer Chemotherapy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147607"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12967-024-05364-8","article-title":"An overview of CCN4 (WISP1) role in human diseases","volume":"22","author":"Singh","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"23647","DOI":"10.1074\/jbc.M110.127050","article-title":"The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination","volume":"285","author":"Karousou","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1074\/jbc.M116.770149","article-title":"A mammalian homolog of the zebrafish transmembrane protein 2 (TMEM2) is the long-sought-after cell-surface hyaluronidase","volume":"292","author":"Yamamoto","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"100008","DOI":"10.1016\/j.mbplus.2019.100008","article-title":"Molecular size-dependent specificity of hyaluronan on functional properties, morphology and matrix composition of mammary cancer cells","volume":"3","author":"Tavianatou","year":"2019","journal-title":"Matrix Biol. Plus"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Hassn Mesrati, M., Syafruddin, S.E., Mohtar, M.A., and Syahir, A. (2021). CD44: A Multifunctional Mediator of Cancer Progression. Biomolecules, 11.","DOI":"10.3390\/biom11121850"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1742-4658.2011.08071.x","article-title":"Hyaluronan-CD44 interactions as potential targets for cancer therapy","volume":"278","author":"Misra","year":"2011","journal-title":"FEBS J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1158\/1078-0432.CCR-11-2521","article-title":"Activation of beta-catenin signaling in androgen receptor-negative prostate cancer cells","volume":"18","author":"Wan","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13058-022-01596-y","article-title":"SRC kinase-mediated signaling pathways and targeted therapies in breast cancer","volume":"24","author":"Luo","year":"2022","journal-title":"Breast Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0135-9","article-title":"Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis","volume":"50","author":"Gautam","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"690690","DOI":"10.1155\/2015\/690690","article-title":"Emerging roles of focal adhesion kinase in cancer","volume":"2015","author":"Tai","year":"2015","journal-title":"Biomed Res. Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40164-023-00446-7","article-title":"Focal adhesion kinase: From biological functions to therapeutic strategies","volume":"12","author":"Tan","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.matbio.2007.11.003","article-title":"Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells","volume":"27","author":"Robledo","year":"2008","journal-title":"Matrix Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1074\/jbc.M115.689653","article-title":"The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways","volume":"291","author":"Kovacevic","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/carcin\/bgy178","article-title":"The metastasis suppressor, NDRG1, attenuates oncogenic TGF-beta and NF-kappaB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells","volume":"40","author":"Menezes","year":"2019","journal-title":"Carcinogenesis"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Kotepui, K., Kotepui, M., Majima, H.J., and Tangpong, J. (2023). Association between NDRG1 protein expression and aggressive features of breast cancer: A systematic review and meta-analysis. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11517-7"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41523-019-0132-8","article-title":"Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients","volume":"5","author":"Paul","year":"2019","journal-title":"npj Breast Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Ramos, R., and Vale, N. (2024). Dual Drug Repurposing: The Example of Saracatinib. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084565"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/2\/160\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:03:07Z","timestamp":1768482187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/2\/160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":77,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["cells15020160"],"URL":"https:\/\/doi.org\/10.3390\/cells15020160","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]}}}